Ballentine Partners’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,472
Closed -$234K – 1184
2026
Q2
$234K Buy
1,472
+52
+4% +$8.86K ﹤0.01% 936
2026
Q1
$256K Sell
1,420
-711
-33% -$141K ﹤0.01% 817
2025
Q4
$462K Sell
2,131
-116
-5% -$25.4K 0.01% 532
2025
Q3
$576K Sell
2,247
-60
-3% -$15.1K 0.01% 454
2025
Q2
$598K Sell
2,307
-135
-6% -$34.3K 0.01% 433
2025
Q1
$595K Buy
2,442
+1,050
+75% +$264K 0.01% 398
2024
Q4
$355K Buy
1,392
+122
+10% +$32.7K 0.01% 534
2024
Q3
$373K Buy
1,270
+93
+8% +$26.2K 0.01% 509
2024
Q2
$285K Buy
1,177
+139
+13% +$33.2K 0.01% 579
2024
Q1
$278K Buy
1,038
+50
+5% +$12.7K 0.01% 560
2023
Q4
$244K Buy
+988
New +$200K 0.01% 570

Other funds holding EFX

Ballentine Partners's EFX Position: Q3 2026 in Review

Ballentine Partners sold out of Equifax (EFX) in Q3 2026, closing a stake of 1,472 shares — an estimated $234K sold.

Ballentine Partners first reported a position in EFX in Q4 2023 and held it in 11 quarters. The position peaked at $598K in Q2 2025. 794 funds tracked by Wall St. Rank hold EFX as of Q3 2026.

  • Ballentine Partners reported no remaining Equifax position as of Q3 2026 after selling out during the quarter.
  • Ballentine Partners sold 1,472 Equifax shares in Q3 2026, an estimated $234K.
  • Ballentine Partners first reported a position in Equifax in Q4 2023 and held it in 11 quarters.
  • Ballentine Partners's Equifax position peaked at $598K in Q2 2025.
  • 794 funds tracked by Wall St. Rank held Equifax as of Q3 2026.

Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.